| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0002 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |